Gallo, CA
Anthony Carmen Gallo, Toronto CA
Patent application number | Description | Published |
---|---|---|
20130205256 | Spatially Driven Content Presentation In A Cellular Environment - Techniques are provided for integrated content presentation via cells arranged geometrically in a cellular environment. Users can navigate various orientations and zoom states of the cellular environment to access information via different applications, different media types, different visual representations and from different underlying content sources. The information can be organized according to various logical relationships. Upon receiving an indication of a zoom state associated with a cell or a group of cells arranged in the cellular environment, a content reference at that zoom state is retrieved. Further, the content reference is resolved to retrieve and output content, including a visual representation associated with the zoom state. | 08-08-2013 |
20140310308 | Spatially Driven Content Presentation In A Cellular Environment - Techniques are provided for integrated content presentation via cells arranged geometrically in a cellular environment. Users can navigate various orientations and zoom states of the cellular environment to access information via different applications, different media types, different visual representations and from different underlying content sources. The information can be organized according to various logical relationships. Upon receiving an indication of a zoom state associated with a cell or a group of cells arranged in the cellular environment, a content reference at that zoom state is retrieved. Further, the content reference is resolved to retrieve and output content, including a visual representation associated with the zoom state. | 10-16-2014 |
Anthony Carmen Gallo, Ontario CA
Patent application number | Description | Published |
---|---|---|
20110283208 | CELLULAR USER INTERFACE - Configurations for a cellular user interface are provided. In one embodiment, a client configuration includes a viewer and a content development kit. A content server distributes cellularized content among several client viewers. Connectors in a scheduled configuration regularly acquire updated content from data sources. An integration server interfaces between the connectors and the content server for distributing content. A monitoring agent assists with content updating upon detecting source changes. A registration server enables cell content update in client viewers through the content server. Cells in the cellularized environment include a visual proxy component and a metadata component. The visual proxy component can be configured for displaying different content at various levels of detail. The metadata component enables intelligent organization and display of content through queries, channels, and data updates. In addition, procedural geometry in the cellularized environment automates the content presentation and provides a flexible arrangement of the cells. | 11-17-2011 |
D. Gregory Gallo, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20090304306 | INFANT CAR SEAT SUSPENDED BAG - A bag for removably attaching to, and suspending from, the handle of an infant car seat. The bag comprises a compartment shaped to fit within the shape of the handle. The compartment is joined to at least one securing member. The securing member is for attaching the compartment to the handle and comprises at least one suspending portion and at least one steadying portion. The suspending portion is for suspending the compartment from the handle and within the shape of the handle. The steadying portion is to prevent the compartment from swinging from the handle. The suspending portion can be integral with the steadying portion. | 12-10-2009 |
Melissa Gallo, Toronto CA
Patent application number | Description | Published |
---|---|---|
20150120471 | Systems Methods and Devices for Generating Secure Electronic Authorization and Payment Processing - The present invention provides a unique way of using mobile or other devices containing accelerometers to provide a unique two-factor authentication comprising something possessed and something known. This involves a combination of the device and the user in the authentication. In one embodiment, the user adds a unique movement pattern (something known) to the device ID (something possessed) to create a unique two-factor authentication. In this way, authentication and security are taken to a high level, beyond biometric identification which is actually just two things possessed. | 04-30-2015 |
Michael Gallo, North Vancouver CA
Patent application number | Description | Published |
---|---|---|
20090258392 | SEQUENCE DIVERSITY GENERATION IN IMMUNOGLOBULINS - Compositions and methods are disclosed for generating immunoglobulin structural diversity in vitro, and in particular, for reducing biases in V region and J segment gene utilization, and for generating immunoglobulin V-D-J recombination events in a manner that does not require D-J recombination to precede V-DJ recombination. Selection of advantageous combinations of immunoglobulin gene elements, including introduction of artificial diversity (D) segment genes and optimization of recombination signal sequence (RSS) efficiency, are disclosed. | 10-15-2009 |
20100255538 | ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR I RECEPTOR - The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulin molecules derived from anti-IGF-IR antibodies and nucleic acid molecules encoding such molecules. The present invention also relates to methods of making anti-IGF-IR antibodies, pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies. The invention also relates to gene therapy methods and transgenic animals comprising nucleic acid molecules of the present invention. | 10-07-2010 |
20110150888 | ANTI-HEPCIDIN ANTIBODIES AND METHODS OF USE - The invention relates to monoclonal antibodies that bind hepcidin and methods of making and using such antibodies. Also provided are methods of treating hepcidin-related disorders. | 06-23-2011 |
20120005767 | ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR I RECEPTOR - The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulin molecules derived from anti-IGF-IR antibodies and nucleic acid molecules encoding such molecules. The present invention also relates to methods of making anti-IGF-IR antibodies, pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies. The invention also relates to gene therapy methods and transgenic animals comprising nucleic acid molecules of the present invention. | 01-05-2012 |
20120258495 | SEQUENCE DIVERSITY GENERATION IN IMMUNOGLOBULINS - Compositions and methods are disclosed for generating immunoglobulin structural diversity in vitro, and in particular, for reducing biases in V region and J segment gene utilization, and for generating immunoglobulin V-D-J recombination events in a manner that does not require D-J recombination to precede V-DJ recombination. Selection of advantageous combinations of immunoglobulin gene elements, including introduction of artificial diversity (D) segment genes and optimization of recombination signal sequence (RSS) efficiency, are disclosed. | 10-11-2012 |
20130236931 | SEQUENCE DIVERSITY GENERATION IN IMMUNOGLOBULINS AND OTHER PROTEINS - An in vitro system for generating sequence, and thus structural, diversity in proteins is described. The system can be constructed using appropriately selected nucleic acid molecules that encode regions of a selected protein or proteins and recombination signal sequences (RSS). The selected protein(s) can be, for example, immunoglobulin (Ig) V, D, J and/or C regions, regions of a non-immunoglobulin (non-Ig) protein, or a combination of Ig regions and non-Ig regions. Assembly of such appropriately selected components and their introduction into suitable recombination-competent host cells allows for recombination between the RSS sequences and introduction of sequence and structural diversity into the protein(s). | 09-12-2013 |
20140120089 | ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR I RECEPTOR - The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulin molecules derived from anti-IGF-IR antibodies and nucleic acid molecules encoding such molecules. The present invention also relates to methods of making anti-IGF-IR antibodies, pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies. The invention also relates to gene therapy methods and transgenic animals comprising nucleic acid molecules of the present invention. | 05-01-2014 |
20140178905 | ANTIBODY CATEGORIZATION BASED ON BINDING CHARACTERISTICS - Methods for categorizing antibodies based on their epitope binding characteristics are described. Methods and systems for determining the epitope recognition properties of different antibodies are provided. Also provided are data analysis processes for clustering antibodies on the basis of their epitope recognition properties and for identifying antibodies having distinct epitope binding characteristics. | 06-26-2014 |
Michael L. Gallo, North Vancouver CA
Patent application number | Description | Published |
---|---|---|
20110021373 | ANTIBODY CATEGORIZATION BASED ON BINDING CHARACTERISTICS - Methods for categorizing antibodies based on their epitope binding characteristics are described. Methods and systems for determining the epitope recognition properties of different antibodies are provided. Also provided are data analysis processes for clustering antibodies on the basis of their epitope recognition properties and for identifying antibodies having distinct epitope binding characteristics. | 01-27-2011 |
20130085074 | Antibody Categorization Based on Binding Characteristics - Methods for categorizing antibodies based on their epitope binding characteristics are described. Methods and systems for determining the epitope recognition properties of different antibodies are provided. Also provided are data analysis processes for clustering antibodies on the basis of their epitope recognition properties and for identifying antibodies having distinct epitope binding characteristics. | 04-04-2013 |
Michele Gallo, Blainville CA
Patent application number | Description | Published |
---|---|---|
20140314680 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof - A dual release oral dosage system/dosage form comprising an immediate release component/composition and a delayed release component/composition is described. Each of the immediate release component/composition and delayed release component/composition comprises one or more of doxylamine, an analog thereof, a derivative thereof, a prodrug thereof, a metabolite thereof and/or a salt thereof, and one or more of pyridoxine, a salt thereof, a metabolite thereof and/or a salt of the metabolite. The dual release oral dosage system/dosage form exhibits an improved pharmacokinetic profile relative to the current Diclectin® formulation and is useful for example for the alleviation of the symptoms of nausea and vomiting, for example in the case of nausea and vomiting in pregnancy (NVP). | 10-23-2014 |
20150025032 | Composition for the management of nausea and vomiting - A pharmaceutical dosage system comprising (a) an effective amount of one or more of Doxylamine, an analog thereof, a derivative thereof, a prodrug thereof, a metabolite thereof and/or a salt thereof; (b) an effective amount of one or more of (i) Pyridoxine, (ii) an analog thereof, (iii) a derivative thereof, (iv) a prodrug thereof, (v) a metabolite thereof and (vi) a salt of any of (i)-(v); and (c) an effective amount of one or more compounds of formula (I) | 01-22-2015 |
20150025033 | Composition for the management of nausea and vomiting - A pharmaceutical dosage system comprising (a) an effective amount of one or more of Doxylamine, an analog thereof, a derivative thereof, a prodrug thereof, a metabolite thereof and/or a salt thereof; (b) an effective amount of one or more of (i) Pyridoxine, (ii) an analog thereof, (iii) a derivative thereof, (iv) a prodrug thereof, (v) a metabolite thereof and (vi) a salt of any of (i)-(v); and (c) an effective amount of one or more compounds of formula (I) | 01-22-2015 |
Steven William Gallo, Laval CA
Patent application number | Description | Published |
---|---|---|
20100083573 | SYSTEM FOR GROWING PLANTS - The present invention relates to a device for covering a plant growing medium. The device is comprised of two parts which may be assembled and placed upon a plant growing medium or assembled over a plant growing medium and existing plant. The device includes a sheet, and aperture defined by the sheet and a chamber. The chamber is suspended below a first portion of the sheet and above the plant growing medium. Liquid is delivered to the chamber through at least one hole defined by the cover and the liquid is dispersed from the chamber to the plant growing medium. The chamber includes a baffle for diverting the liquid to provide even distribution of the liquid to the plant growing medium. | 04-08-2010 |
Steven William Gallo, Montreal CA
Patent application number | Description | Published |
---|---|---|
20080244967 | Cover for plant growing medium - The present invention relates to a device for covering a plant growing medium. The device includes a sheet that defines an aperture. One or more protrusions extends from the sheet to engage a top surface of the plant growing medium. A wall is integrally attached to each edge of the sheet. Each wall has a series of ridges. | 10-09-2008 |
20090119982 | SYSTEM FOR GROWING PLANTS - The present invention relates to a device for covering a plant growing medium. The device includes a sheet and an aperture defined by the sheet. A first portion of the sheet surrounds the aperture. A second portion of the sheet has at least one ledge for engaging a top surface of the plant growing medium. The second portion of the sheet is integrated with the first portion of the sheet such that the at least one ledge is situated at a height below the height of the first portion of the sheet. | 05-14-2009 |
20100212222 | SYSTEM FOR GROWING PLANTS - The present invention relates to a device for covering a plant growing medium. The device includes a sheet and an aperture defined by the sheet. A first portion of the sheet surrounds the aperture. A second portion of the sheet has at least one ledge for engaging a top surface of the plant growing medium. The second portion of the sheet is integrated with the first portion of the sheet such that the at least one ledge is situated at a height below the height of the first portion of the sheet. | 08-26-2010 |
20110209403 | COVER FOR PLANT GROWING MEDIUM - The present invention relates to a device for covering a plant growing medium. The device includes a sheet that defines an aperture. One or more protrusions extend from the sheet to engage a top surface of the plant growing medium. A wall is integrally attached to each edge of the sheet. Each wall has a series of ridges. | 09-01-2011 |